Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 146 posts found.

Professor Dame Sally Davies

Pfizer partners with NIHR to boosts UK R&D

July 1, 2015
Research and Development Manchester, NIHR, Pfizer, R&D, Sally Davies

Pfizer has signed an agreement with the National Institute for Health Research Clinical Research Network to conduct more clinical research …

News
BMS image

BMS enters gene therapy development deal

April 7, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …

News
research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014
Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …

News
Teva image

Teva to ditch R&D in cancer and women’s health

October 6, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, MS, R&D, Teva, cuts, generics

Teva will stop research into oncology and women’s health in order to cut costs and focus more on generics and …

News
AstraZeneca logo

AstraZeneca rejects Pfizer’s ‘final offer’

May 19, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …

News
george_osborne_budget_day_2014

BIA welcomes budget statement

March 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme

An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …

News
Alderley park image

AstraZeneca sells Alderley Park

March 13, 2014
Research and Development, Sales and Marketing AstraZeneca, Manchester, Osborne, R&D, alderley park, research

AstraZeneca has sold its former R&D site in Cheshire to a public-private consortium for an undisclosed sum, and expects the …

News
Forest labs image

Forest cuts jobs in restructure

December 4, 2013
Research and Development, Sales and Marketing Forest Labs, R&D, US, cuts

Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …

News
research image

Report: ‘R&D isn’t paying’

December 3, 2013
Research and Development, Sales and Marketing Deloitte, R&D, pharma, research and development, reuters

On average, the world’s biggest pharma companies are not getting enough of a return out of their R&D efforts, according …

News
Eisai image

Eisai reorganises R&D

December 2, 2013
Research and Development, Sales and Marketing Eisai, R&D, cfu, epcs, pcu, reorganisation

Tokyo-based Eisai is to axe 130 jobs in Europe and the US as part of an attempt to shake up …

News
Department of health

Coalition launches rare disease strategy

November 22, 2013
Research and Development, Sales and Marketing DoH, NHS, R&D, rare disease

The Department of Health has launched the UK’s first strategy on rare diseases as part of a bid to boost …

News
Merck sign

Merck axes 8,500 more jobs

October 2, 2013
Medical Communications, Research and Development, Sales and Marketing Jobs, Merck, R&D, cuts

News
amgen image

Amgen to open Chinese R&D centre

September 26, 2013
Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang

Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …

News
teva_copy

Teva in Cancer Research UK tie-up

September 20, 2013
Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, R&D, Teva

News
NICE image

NICE queries pharma R&D costs

September 5, 2013
Research and Development, Sales and Marketing Dillon, NICE, Pfizer, R&D

NICE has questioned whether pharma really spends as much as it says it does on bringing new treatments to market …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026